Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.50 |
| ▸ | SELP | P16109 | 1/20 | 0.50 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.45 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.45 |
| ▸ | F3 | P13726 | 10/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | F10 | P00742 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18979864 | 0.97 | PTPN1 (0.53) | PTPN1SELPHSD11B1HSD11B2F3 | |
| SCHEMBL17982560 | 0.97 | PTPN1 (0.53) | PTPN1SELPHSD11B1HSD11B2F3 | |
| SCHEMBL21202083 | 0.97 | PTPN1 (0.53) | PTPN1SELPHSD11B1HSD11B2F3 | |
| SCHEMBL16048075 | 0.97 | PTPN1 (0.53) | PTPN1SELPHSD11B1HSD11B2F3 | |
| SCHEMBL24961200 | 0.94 | SELP (0.49) | PTPN1SELPHSD11B1HSD11B2F3 | |
| SCHEMBL26711277 | 0.94 | SELP (0.49) | PTPN1SELPHSD11B1HSD11B2F3 | |
| SCHEMBL19755909 | 0.93 | PTPN1 (0.53) | PTPN1SELPHSD11B1HSD11B2F3 | |
| SCHEMBL2321885 | 0.90 | PTPN1 (0.59) | PTPN1SELPHSD11B1HSD11B2F3 | |
| SCHEMBL18088365 | 0.90 | PTPN1 (0.59) | PTPN1SELPHSD11B1HSD11B2F3 | |
| SCHEMBL2321888 | 0.90 | PTPN1 (0.59) | PTPN1SELPHSD11B1HSD11B2F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170369922-A1 | PRODUCTION OF STEVIOL GLYCOSIDE IN RECOMBINANT HOSTS | DANSTAR FERMENT AG (CH) | 2017-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170369922-A1 | PRODUCTION OF STEVIOL GLYCOSIDE IN RECOMBINANT HOSTS | ERG28, KISS1R, STT3A | PTPN1 4547/4885SELP 1162/4885HSD11B1 160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.